NEW YORK—A federal judge on Wednesday dismissed a proposed class action lawsuit by consumers who accused Pfizer Inc. of failing to disclose the presence of cancer-causing agents in Chantix before recalling the anti-smoking drug. U.S. District Judge Denise Cote in Manhattan found no plausible allegations that Pfizer had a duty to disclose that Chantix was…
Lawsuit Over Pfizer’s Disclosures Before Chantix Recall Is Dismissed
February 18, 2022
admin
Business & EconomycancerChantixCompanieseconomyJudiciarylawsuitLocal NewsNew YorkPfizerRegional-Local NewsUSUS News
0 Comment
Pfizer Expands Recall of Anti-Smoking Drug Containing Cancer-Linked Nitrosamine
Pfizer has announced a recall of the anti-smoking treatment Chantix due to the presence of unacceptably high levels of N-nitroso-varenicline, a substance whose long-term use has been linked to a higher risk of cancer. The drugmaker said on Sept. 16 that it is voluntarily recalling all lots of 0.5 mg and 1 mg Chantix tablets distributed…
-
Recent Posts
-
Archives
- May 2025
- April 2025
- July 2023
- June 2023
- May 2023
- April 2023
- March 2023
- February 2023
- January 2023
- December 2022
- November 2022
- October 2022
- September 2022
- August 2022
- July 2022
- June 2022
- May 2022
- April 2022
- March 2022
- February 2022
- January 2022
- December 2021
- November 2021
- October 2021
- September 2021
- August 2021
- July 2021
- June 2021
- May 2021
- April 2021
- March 2021
- February 2021
- January 2021
- December 2020
- September 2013
- July 2013
- March 2013
- January 2013
- December 2012
- November 2012
- December 1
-
Meta